H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Physiology - Gastrointestinal and Liver Physiology

• Publication date

  2014-07-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1152/ajpgi.00027.2014PMID 24852568PMCID PMC4101675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile Salt Export Pump

  2020cited by this paper
• Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.

  2012cited by this paper
• The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance.

  2012cited by this paper
• The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.

  2012cited by this paper
• BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.

  2012cited by this paper
• Deficiency in apolipoprotein E has a protective effect on diet‐induced nonalcoholic fatty liver disease in mice

  2011cited by this paper
• Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

  2011cited by this paper
• Organic anion–transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2‐null mice

  2011cited by this paper
• Histamine Deficiency Decreases Atherosclerosis and Inflammatory Response in Apolipoprotein E Knockout Mice Independently of Serum Cholesterol Level

  2011cited by this paper
• Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation

  2011cited by this paper
• Quantification of the transporter substrate fexofenadine in cell lysates by liquid chromatography/tandem mass spectrometry.

  2011cited by this paper
• Glucose and Insulin Induction of Bile Acid Synthesis

  2011cited by this paper
• Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice[S]

  2010cited by this paper
• Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice.

  2010cited by this paper
• Histamine in the CNS

  2010cited by this paper
• Lack of apoE causes alteration of cytokines expression in young mice liver

  2010cited by this paper
• Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey

  2010cited by this paper
• Effect of Obesity on the Pharmacokinetics of Drugs in Humans

  2010cited by this paper
• Bile acids: regulation of synthesis

  2009cited by this paper
• Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice

  2008cited by this paper
• Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

  2008cited by this paper
• The bile salt export pump

  2007cited by this paper
• Involvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance

  2007cited by this paper
• Dose translation from animal to human studies revisited

  2007cited by this paper
• Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis

  2007cited by this paper
• The role of histamine in regulation of immune responses.

  2006cited by this paper
• Histamine and its receptors

  2006cited by this paper
• Histamine-induced vasodilation and vasoconstriction in the mesenteric resistance artery of the rat.

  2006cited by this paper
• CONTRIBUTION OF OATP (ORGANIC ANION-TRANSPORTING POLYPEPTIDE) FAMILY TRANSPORTERS TO THE HEPATIC UPTAKE OF FEXOFENADINE IN HUMANS

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene.

  2003cited by this paper
• Neuronal histamine regulates food intake, adiposity, and uncoupling protein expression in agouti yellow (A(y)/a) obese mice.

  2003cited by this paper
• Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype.

  2002cited by this paper
• Nonalcoholic fatty liver disease.

  2002cited by this paper
• Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice.

  2001cited by this paper
• Central infusion of histamine reduces fat accumulation and upregulates UCP family in leptin-resistant obese mice.

  2001cited by this paper
• Histamine regulates food intake through modulating noradrenaline release in the para-ventricular nucleus.

  1999cited by this paper
• Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.

  1998cited by this paper
• Hypothalamic neuronal histamine: implications of its homeostatic control of energy metabolism.

  1997cited by this paper
• ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

  1994cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• The hepatic metabolism and biliary excretion of benzo[a]pyrene in guinea-pigs fed normal, high-fat or high-cholesterol diets.

  1986cited by this paper
• Histamine-containing neurons in the rat hypothalamus.

  1984cited by this paper
• Evidence for the presence of a histaminergic neuron system in the rat brain: an immunohistochemical analysis.

  1983cited by this paper

• Brain histaminergic system: an emerging target for the treatment of feeding and eating-related disorders.

  2025cites this paper
• Structural, Spectroscopic, and Docking Analysis of N,O‐Donor Ligand Metal Complex Nanoparticles With Hypolipidemic Effects via Lipoprotein Lipase Activation in High‐Fat Diet Mice

  2024cites this paper
• Targeting histamine in metabolic syndrome: Insights and therapeutic potential.

  2024cites this paper
• In utero exposure to antihistamines and risk of hepatocellular carcinoma in a multigenerational cohort

  2024cites this paper
• Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines

  2022cites this paper
• The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way

  2022cites this paper
• A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes.

  2021cites this paper
• Searching for the correlations between the use of different groups of pharmaceuticals from wastewaters.

  2021cites this paper
• Obesity and the pharmacotherapy of bipolar disorder Otyłość a farmakoterapia choroby afektywnej dwubiegunowej

  2020cites this paper
• Obesity and the pharmacotherapy of bipolar disorder

  2020cites this paper
• Assessing the effect of prolonged use of desloratadine on adipose Brillouin shift and composition in rats

  2020cites this paper
• The protective role of l-carnitine against 1st- and 2nd-generation antihistamine-induced liver injury in mice

  2019cites this paper
• Mast Cell-Derived Histamine Regulates Liver Ketogenesis via Oleoylethanolamide Signaling.

  2019cites this paper
• Inhibition of hepatic apolipoprotein A‐I gene expression by histamine

  2018cites this paper
• Effects of the Antihistamine Fexofenadine on Body Fat, Glucose and Body Weight: Impact of Dietary Fat Type and Pre-Drug Run-in Period

  2017influential citation
• Histamine and Appetite

  2016cites this paper
• The histaminergic system as a target for the prevention of obesity and metabolic syndrome.

  2016cites this paper
• Seeing cells in a new light: a renaissance of Brillouin spectroscopy

  2016cites this paper
• Effects of Chronic Exposure to the Antipsychotic Olanzapine on Metabolism and Hormones: Is There an Interaction with Dietary Fat Levels?

  2016cites this paper
• Histamine H2-Receptor Antagonist Use Is Associated With Lower Prevalence of Nonalcoholic Fatty Liver Disease: A Population-based Study From the National Health and Nutrition Examination Survey, 2001-2006

  2015cites this paper
• Manipulating the Circadian and Sleep Cycles to Protect Against Metabolic Disease

  2015cites this paper
• Manipulating the circadian and sleep cycles to protect against metabolic disease

  2015cites this paper
• Chronic Ingestion of H1-Antihistamines Increase Progression of Atherosclerosis in Apolipoprotein E-/- Mice

  2014cites this paper
• Effect of histamine on lipid composition of rat bile

  2014cites this paper